NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 135,900 shares, a drop of 29.3% from the August 15th total of 192,200 shares. Based on an average daily volume of 286,900 shares, the days-to-cover ratio is presently 0.5 days.
NovaBay Pharmaceuticals Stock Performance
NBY remained flat at $0.47 during trading on Friday. 81,222 shares of the company’s stock were exchanged, compared to its average volume of 236,330. The company has a market capitalization of $2.00 million, a price-to-earnings ratio of -0.05 and a beta of 2.82. NovaBay Pharmaceuticals has a 1 year low of $0.36 and a 1 year high of $19.57.
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Free Report) last announced its earnings results on Tuesday, August 13th. The biopharmaceutical company reported ($1.37) earnings per share for the quarter. The company had revenue of $2.40 million during the quarter. NovaBay Pharmaceuticals had a negative return on equity of 146.20% and a negative net margin of 79.70%. As a group, research analysts forecast that NovaBay Pharmaceuticals will post -2.54 EPS for the current year.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Featured Stories
- Five stocks we like better than NovaBay Pharmaceuticals
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What Does Downgrade Mean in Investing?
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- What is the Shanghai Stock Exchange Composite Index?
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.